Another trial date has been set for MRI patent litigation filed by MRI vendor Fonar againstGE, Hitachi and several imaging centers. The case is scheduledto go to trial April 10, according to Fonar attorney Ronald Schutzof Robins, Kaplan, Miller and
Another trial date has been set for MRI patent litigation filed by MRI vendor Fonar againstGE, Hitachi and several imaging centers. The case is scheduledto go to trial April 10, according to Fonar attorney Ronald Schutzof Robins, Kaplan, Miller and Ciresi of Minneapolis.
Fonar, of Melville, NY, filed suit against the companies inSeptember, 1992, in U.S. District Court of Eastern New York inHauppauge, NY, claiming that its basic patents for MRI technologyhad been infringed (SCAN 11/23/94). A trial date had been setfor December but was later postponed. Fonar is asking for $362million in damages.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.